HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hsing-Hui Su Selected Research

lumbrokinase

1/2018Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury.
10/2016Lumbrokinase attenuates myocardial ischemia-reperfusion injury by inhibiting TLR4 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hsing-Hui Su Research Topics

Disease

3Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 10/2016
2Myocardial Infarction
01/2020 - 01/2017
2Reperfusion Injury
01/2018 - 10/2016
2Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 10/2016
1Ischemic Stroke
12/2021
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2021
1Cardiac Arrhythmias (Arrythmia)
01/2020
1Cardiomegaly (Heart Hypertrophy)
01/2019
1Inflammation (Inflammations)
01/2018
1Infarction (Infarctions)
10/2016
1Stroke (Strokes)
10/2016

Drug/Important Bio-Agent (IBA)

2Factor XI (Plasma Thromboplastin Antecedent)IBA
12/2021 - 01/2019
2lumbrokinaseIBA
01/2018 - 10/2016
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
12/2021
1paeonolIBA
01/2020
1Troponin IIBA
01/2020
1Transforming Growth Factor beta (TGF-beta)IBA
01/2019
1Sirtuin 1IBA
01/2018
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2017
1Inflammation MediatorsIBA
10/2016
1Fibrinolytic Agents (Antithrombotic Agents)IBA
10/2016